International Conference on Immunology and Clinical Trials
(ICIACT-26)

15th November 2026 || Chandigarh - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Conference on Immunology and Clinical Trials (ICIACT), scheduled to be held on 15th November 2026 in Chandigarh, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Immunology.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Advancements in Immunotherapy
    This track focuses on the latest developments in immunotherapy, including novel approaches and combination therapies. Participants will explore the efficacy and safety profiles of emerging immunotherapeutic agents in clinical trials. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 02 – Vaccine Development and Clinical Trials
    This session will delve into the innovative strategies for vaccine development, emphasizing the role of clinical trials in assessing safety and efficacy. Discussions will include recent successes and challenges in vaccine research against infectious diseases and cancers. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 03 – Biomarkers in Immunology
    This track will highlight the identification and validation of biomarkers that predict immune responses and treatment outcomes. Participants will discuss the implications of biomarker research for personalized medicine in immunology. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 04 – Cytokine Signaling Pathways
    This session will explore the intricate cytokine signaling pathways that regulate immune responses. Researchers will present findings on how these pathways can be targeted for therapeutic interventions in various diseases. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 05 – Translational Research in Immunology
    This track emphasizes the translation of basic immunological research into clinical applications. Presentations will focus on bridging the gap between laboratory findings and patient care in immunology. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 06 – Molecular Mechanisms of Immune Regulation
    Participants will investigate the molecular mechanisms underlying immune regulation, including the role of regulatory T cells and immune checkpoints. This session aims to enhance understanding of immune tolerance and its therapeutic potential. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 07 – Clinical Immunology and Patient Outcomes
    This track will examine the relationship between clinical immunology practices and patient outcomes. Discussions will focus on how immunological assessments can inform treatment decisions and improve patient care. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 08 – Immunopathology: Mechanisms and Therapies
    This session will address the pathophysiological mechanisms of immune-mediated diseases and the therapeutic strategies to manage them. Participants will share insights into the latest research on immunopathology and its clinical implications. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 09 – Cellular and Humoral Immunity in Disease
    This track will explore the roles of cellular and humoral immunity in the context of various diseases. Researchers will present findings on how these immune responses can be harnessed for therapeutic purposes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 10 – Drug Development in Immunology
    This session will focus on the drug development process specific to immunological therapies, including preclinical and clinical trial phases. Participants will discuss challenges and innovations in bringing new immunomodulatory drugs to market. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 11 – Innovations in Immunodiagnostics
    This track will highlight the latest advancements in immunodiagnostic techniques and their applications in clinical settings. Presentations will cover novel assays and technologies that enhance the detection and monitoring of immune responses. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 4 SDG 4
    Quality Education
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228